The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension

Chern En Chiang, Tzung Dau Wang, Tsung Hsien Lin, Hung I. Yeh, Ping Yen Liu, Hao Min Cheng, Ting Hsing Chao, Chen Huan Chen, Kou Gi Shyu, Kwo Chang Ueng, Chung Yin Chen, Pao Hsien Chu, Shih Hsien Sung, Kang Ling Wang, Yi Heng Li, Kuo Yang Wang, Fu Tien Chiang, Wen Ter Lai, Jyh Hong Chen, Wen Jone Chen & 4 others San Jou Yeh, Ming Fong Chen, Shing Jong Lin, Jiunn-Lee Lin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Hypertension (HT) is the most important risk factor for cardiovascular diseases. Over the past 25 years, the number of individuals with hypertension and the estimated associated deaths has increased substantially. There have been great debates in the past few years on the blood pressure (BP) targets. The 2013 European Society of Hypertension and European Society of Cardiology HT guidelines suggested a unified systolic BP target of 140 mmHg for both high-risk and low-risk patients. The 2014 Joint National Committee report further raised the systolic BP targets to 150 mmHg for those aged ≥ 60 years, including patients with stroke or coronary heart disease, and raised the systolic BP target to 140 mmHg for diabetes. Instead, the 2015 Hypertension Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society suggested more aggressive BP targets of < 130/80 mmHg for patients with diabetes, coronary heart disease, chronic kidney disease with proteinuria, and atrial fibrillation patients on antithrombotic therapy. Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120 mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged ≥ 75 years, using unattended automated office BP measurement. When traditional office BP measurement is applied,we suggested BP target of < 140/90 mmHg for elderly patients with an age ≥ 75 years. Other BP targets with traditional office BP measurement remain unchanged. With these more aggressive BP targets, it is foreseeable that the cardiovascular events will decrease substantially in Taiwan.

Original languageEnglish
Pages (from-to)213-225
Number of pages13
JournalActa Cardiologica Sinica
Volume33
Issue number3
DOIs
Publication statusPublished - Jan 1 2017
Externally publishedYes

Fingerprint

Cardiology
Taiwan
Guidelines
Blood Pressure
Hypertension
Coronary Disease
Chronic Renal Insufficiency
Committee Membership
Proteinuria

Keywords

  • Guidelines
  • Hypertension
  • Taiwan hypertension society
  • Taiwan society of cardiology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension. / Chiang, Chern En; Wang, Tzung Dau; Lin, Tsung Hsien; Yeh, Hung I.; Liu, Ping Yen; Cheng, Hao Min; Chao, Ting Hsing; Chen, Chen Huan; Shyu, Kou Gi; Ueng, Kwo Chang; Chen, Chung Yin; Chu, Pao Hsien; Sung, Shih Hsien; Wang, Kang Ling; Li, Yi Heng; Wang, Kuo Yang; Chiang, Fu Tien; Lai, Wen Ter; Chen, Jyh Hong; Chen, Wen Jone; Yeh, San Jou; Chen, Ming Fong; Lin, Shing Jong; Lin, Jiunn-Lee.

In: Acta Cardiologica Sinica, Vol. 33, No. 3, 01.01.2017, p. 213-225.

Research output: Contribution to journalArticle

Chiang, CE, Wang, TD, Lin, TH, Yeh, HI, Liu, PY, Cheng, HM, Chao, TH, Chen, CH, Shyu, KG, Ueng, KC, Chen, CY, Chu, PH, Sung, SH, Wang, KL, Li, YH, Wang, KY, Chiang, FT, Lai, WT, Chen, JH, Chen, WJ, Yeh, SJ, Chen, MF, Lin, SJ & Lin, J-L 2017, 'The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension', Acta Cardiologica Sinica, vol. 33, no. 3, pp. 213-225. https://doi.org/10.6515/ACS20170421A
Chiang, Chern En ; Wang, Tzung Dau ; Lin, Tsung Hsien ; Yeh, Hung I. ; Liu, Ping Yen ; Cheng, Hao Min ; Chao, Ting Hsing ; Chen, Chen Huan ; Shyu, Kou Gi ; Ueng, Kwo Chang ; Chen, Chung Yin ; Chu, Pao Hsien ; Sung, Shih Hsien ; Wang, Kang Ling ; Li, Yi Heng ; Wang, Kuo Yang ; Chiang, Fu Tien ; Lai, Wen Ter ; Chen, Jyh Hong ; Chen, Wen Jone ; Yeh, San Jou ; Chen, Ming Fong ; Lin, Shing Jong ; Lin, Jiunn-Lee. / The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension. In: Acta Cardiologica Sinica. 2017 ; Vol. 33, No. 3. pp. 213-225.
@article{0ca49d8d95044bd684148b8b3c955c00,
title = "The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension",
abstract = "Hypertension (HT) is the most important risk factor for cardiovascular diseases. Over the past 25 years, the number of individuals with hypertension and the estimated associated deaths has increased substantially. There have been great debates in the past few years on the blood pressure (BP) targets. The 2013 European Society of Hypertension and European Society of Cardiology HT guidelines suggested a unified systolic BP target of 140 mmHg for both high-risk and low-risk patients. The 2014 Joint National Committee report further raised the systolic BP targets to 150 mmHg for those aged ≥ 60 years, including patients with stroke or coronary heart disease, and raised the systolic BP target to 140 mmHg for diabetes. Instead, the 2015 Hypertension Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society suggested more aggressive BP targets of < 130/80 mmHg for patients with diabetes, coronary heart disease, chronic kidney disease with proteinuria, and atrial fibrillation patients on antithrombotic therapy. Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120 mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged ≥ 75 years, using unattended automated office BP measurement. When traditional office BP measurement is applied,we suggested BP target of < 140/90 mmHg for elderly patients with an age ≥ 75 years. Other BP targets with traditional office BP measurement remain unchanged. With these more aggressive BP targets, it is foreseeable that the cardiovascular events will decrease substantially in Taiwan.",
keywords = "Guidelines, Hypertension, Taiwan hypertension society, Taiwan society of cardiology",
author = "Chiang, {Chern En} and Wang, {Tzung Dau} and Lin, {Tsung Hsien} and Yeh, {Hung I.} and Liu, {Ping Yen} and Cheng, {Hao Min} and Chao, {Ting Hsing} and Chen, {Chen Huan} and Shyu, {Kou Gi} and Ueng, {Kwo Chang} and Chen, {Chung Yin} and Chu, {Pao Hsien} and Sung, {Shih Hsien} and Wang, {Kang Ling} and Li, {Yi Heng} and Wang, {Kuo Yang} and Chiang, {Fu Tien} and Lai, {Wen Ter} and Chen, {Jyh Hong} and Chen, {Wen Jone} and Yeh, {San Jou} and Chen, {Ming Fong} and Lin, {Shing Jong} and Jiunn-Lee Lin",
year = "2017",
month = "1",
day = "1",
doi = "10.6515/ACS20170421A",
language = "English",
volume = "33",
pages = "213--225",
journal = "Acta Cardiologica Sinica",
issn = "1011-6842",
publisher = "Republic of China Society of Cardiology",
number = "3",

}

TY - JOUR

T1 - The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension

AU - Chiang, Chern En

AU - Wang, Tzung Dau

AU - Lin, Tsung Hsien

AU - Yeh, Hung I.

AU - Liu, Ping Yen

AU - Cheng, Hao Min

AU - Chao, Ting Hsing

AU - Chen, Chen Huan

AU - Shyu, Kou Gi

AU - Ueng, Kwo Chang

AU - Chen, Chung Yin

AU - Chu, Pao Hsien

AU - Sung, Shih Hsien

AU - Wang, Kang Ling

AU - Li, Yi Heng

AU - Wang, Kuo Yang

AU - Chiang, Fu Tien

AU - Lai, Wen Ter

AU - Chen, Jyh Hong

AU - Chen, Wen Jone

AU - Yeh, San Jou

AU - Chen, Ming Fong

AU - Lin, Shing Jong

AU - Lin, Jiunn-Lee

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Hypertension (HT) is the most important risk factor for cardiovascular diseases. Over the past 25 years, the number of individuals with hypertension and the estimated associated deaths has increased substantially. There have been great debates in the past few years on the blood pressure (BP) targets. The 2013 European Society of Hypertension and European Society of Cardiology HT guidelines suggested a unified systolic BP target of 140 mmHg for both high-risk and low-risk patients. The 2014 Joint National Committee report further raised the systolic BP targets to 150 mmHg for those aged ≥ 60 years, including patients with stroke or coronary heart disease, and raised the systolic BP target to 140 mmHg for diabetes. Instead, the 2015 Hypertension Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society suggested more aggressive BP targets of < 130/80 mmHg for patients with diabetes, coronary heart disease, chronic kidney disease with proteinuria, and atrial fibrillation patients on antithrombotic therapy. Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120 mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged ≥ 75 years, using unattended automated office BP measurement. When traditional office BP measurement is applied,we suggested BP target of < 140/90 mmHg for elderly patients with an age ≥ 75 years. Other BP targets with traditional office BP measurement remain unchanged. With these more aggressive BP targets, it is foreseeable that the cardiovascular events will decrease substantially in Taiwan.

AB - Hypertension (HT) is the most important risk factor for cardiovascular diseases. Over the past 25 years, the number of individuals with hypertension and the estimated associated deaths has increased substantially. There have been great debates in the past few years on the blood pressure (BP) targets. The 2013 European Society of Hypertension and European Society of Cardiology HT guidelines suggested a unified systolic BP target of 140 mmHg for both high-risk and low-risk patients. The 2014 Joint National Committee report further raised the systolic BP targets to 150 mmHg for those aged ≥ 60 years, including patients with stroke or coronary heart disease, and raised the systolic BP target to 140 mmHg for diabetes. Instead, the 2015 Hypertension Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society suggested more aggressive BP targets of < 130/80 mmHg for patients with diabetes, coronary heart disease, chronic kidney disease with proteinuria, and atrial fibrillation patients on antithrombotic therapy. Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120 mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged ≥ 75 years, using unattended automated office BP measurement. When traditional office BP measurement is applied,we suggested BP target of < 140/90 mmHg for elderly patients with an age ≥ 75 years. Other BP targets with traditional office BP measurement remain unchanged. With these more aggressive BP targets, it is foreseeable that the cardiovascular events will decrease substantially in Taiwan.

KW - Guidelines

KW - Hypertension

KW - Taiwan hypertension society

KW - Taiwan society of cardiology

UR - http://www.scopus.com/inward/record.url?scp=85019392271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019392271&partnerID=8YFLogxK

U2 - 10.6515/ACS20170421A

DO - 10.6515/ACS20170421A

M3 - Article

VL - 33

SP - 213

EP - 225

JO - Acta Cardiologica Sinica

JF - Acta Cardiologica Sinica

SN - 1011-6842

IS - 3

ER -